Cargando…

Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer

The murine MC-38 colorectal cancer model is a commonly used model for cancer with high mutational burden, which is sensitive for immune checkpoint immunotherapy. We set out to analyze endogenous CD8(+) T cell responses to MC-38 neo-antigens in tumor-bearing mice and after anti-PD-L1 checkpoint thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hos, Brett J., Camps, Marcel G.M., van den Bulk, Jitske, Tondini, Elena, van den Ende, Thomas C., Ruano, Dina, Franken, Kees, Janssen, George M.C., Ru, Arnoud, Filippov, Dmitri V., Arens, Ramon, van Veelen, Peter A., Miranda, Noel, Ossendorp, Ferry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458608/ https://www.ncbi.nlm.nih.gov/pubmed/32923109 http://dx.doi.org/10.1080/2162402X.2019.1673125

Ejemplares similares

Approaches to Improve Chemically Defined Synthetic Peptide Vaccines
por: Hos, Brett J., et al.
Publicado: (2018)

A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control
por: Tondini, Elena, et al.
Publicado: (2019)

Differential Influence on Cytotoxic T Lymphocyte Epitope Presentation by Controlled Expression of Either Proteasome Immunosubunits or Pa28
por: van Hall, Thorbald, et al.
Publicado: (2000)

Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control
por: Tondini, Elena, et al.
Publicado: (2022)

Cancer immunotherapy: broadening the scope of targetable tumours
por: van den Bulk, Jitske, et al.
Publicado: (2018)

Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
por: van den Bulk, Jitske, et al.
Publicado: (2021)

The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion
por: Welten, Suzanne PM, et al.
Publicado: (2015)

Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified Epitopes
por: van der Gracht, Anouk M. F., et al.
Publicado: (2018)

Identification and ranking of recurrent neo-epitopes in cancer
por: Blanc, Eric, et al.
Publicado: (2019)

A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
por: Pardieck, Iris N., et al.
Publicado: (2022)

Self-Adjuvanting Cancer Vaccines from Conjugation-Ready Lipid A Analogues and Synthetic Long Peptides
por: Reintjens, Niels R. M., et al.
Publicado: (2020)

Multivalent, Stabilized Mannose‐6‐Phosphates for the Targeted Delivery of Toll‐Like Receptor Ligands and Peptide Antigens
por: Reintjens, Niels R. M., et al.
Publicado: (2020)

Local immunomodulation for cancer therapy: Providing treatment where needed
por: Fransen, Marieke F, et al.
Publicado: (2013)

Cytofast: A workflow for visual and quantitative analysis of flow and mass cytometry data to discover immune signatures and correlations
por: Beyrend, Guillaume, et al.
Publicado: (2018)

MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression
por: Schrörs, Barbara, et al.
Publicado: (2023)

Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
por: Van Hoecke, Lien, et al.
Publicado: (2018)

PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors
por: Beyrend, Guillaume, et al.
Publicado: (2019)

Therapeutic anti-tumor immunity directed against neo-epitopes by intratumor delivery of mRNA encoding MLKL
por: Van Hoecke, Lien, et al.
Publicado: (2018)

Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets
por: Rosendahl Huber, S. K., et al.
Publicado: (2015)

Neoantigen Targetability in Progressive Advanced Melanoma
por: van den Bulk, Jitske, et al.
Publicado: (2023)

The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis
por: van den Ende, Tom, et al.
Publicado: (2019)

Enhanced Cross-Presentation and Improved CD8(+) T Cell Responses after Mannosylation of Synthetic Long Peptides in Mice
por: Rauen, Judith, et al.
Publicado: (2014)

Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication
por: Zom, Gijs G., et al.
Publicado: (2018)

Characterizing T cell responses to enzymatically modified beta cell neo-epitopes
por: Nguyen, Hai, et al.
Publicado: (2023)

Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
por: Ossendorp, Ferry, et al.
Publicado: (1998)

Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
por: Sow, Heng Sheng, et al.
Publicado: (2019)

Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights
por: Fransen, Marieke F., et al.
Publicado: (2021)

Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies
por: Arvanitidis, A., et al.
Publicado: (2016)

The Role of β Cell Stress and Neo-Epitopes in the Immunopathology of Type 1 Diabetes
por: Piganelli, Jon D., et al.
Publicado: (2021)

Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
por: Tomasi, Michele, et al.
Publicado: (2021)

A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources
por: Xiang, Haitao, et al.
Publicado: (2022)

Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination
por: Rad-Malekshahi, Mazda, et al.
Publicado: (2017)

Genetic diversity, demographic history and neo-sex chromosomes in the Critically Endangered Raso lark
por: Dierickx, Elisa G., et al.
Publicado: (2020)

Autophagy regulates long‐term cross‐presentation by murine dendritic cells
por: Ho, Nataschja I., et al.
Publicado: (2021)

CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden
por: van den Bulk, Jitske, et al.
Publicado: (2023)

Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
por: van den Ende, Thomas C., et al.
Publicado: (2020)

Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles
por: Da Silva, Candido G., et al.
Publicado: (2019)

Efficient Identification of Novel Hla-A*0201–Presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen Prame by Proteasome-Mediated Digestion Analysis
por: Kessler, Jan H., et al.
Publicado: (2001)

De novo Nanopore Genome Sequencing of the Clinical Diutina catenulata Type-strain CBS565
por: Boden, Sander, et al.
Publicado: (2022)

Sustained cross‐presentation capacity of murine splenic dendritic cell subsets in vivo
por: Ho, Nataschja I., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mrvgurvt1ojahd68nh9665rv11